FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

28987511000001108: Rivastigmine 3mg capsules (Crescent Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
91055301000001113 Rivastigmine 3mg capsules (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
91055401000001117 Rivastigmine 3mg capsules (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Is a Product containing precisely rivastigmine (as rivastigmine tartrate) 3 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Has active ingredient Rivastigmine tartrate false Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Has specific active ingredient Rivastigmine tartrate true Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rivastigmine true Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rivastigmine 3mg capsules (Crescent Pharma Ltd) Has basis of strength substance Rivastigmine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rivastigmine 3mg capsules (Crescent Pharma Ltd) 28 capsule 2 x 14 capsules Has AMP True Rivastigmine 3mg capsules (Crescent Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start